ir.navidea.com

Navidea Biopharmaceuticals Inc. -Investors

Business Units and Joint Ventures. Annual Meeting and Proxy. Corporate Ethics and Conduct. Data as of 08/07/15 4:00 pm ET. Minimum 20 minute delay. Annual Meeting and Proxy. Navidea Reports Second Quarter 2015 Financial Results; Reiterates 2015 Lymphoseek Revenue Guidance. Navidea Awarded $1.7 Million Fast Track NIH SBIR Grant for Evaluation of Manocept in Rheumatoid Arthritis. Navidea and Massachusetts General Hospital to Evaluate Manocept for Detection of Cardiovascular Disease with NIH Grant.

http://ir.navidea.com/

OVERVIEW OF ir.navidea.com

TRAFFIC RANK

>1,000,000

REVIEWS

0

PAGES IN THIS WEBSITE

0

LINKS TO THIS WEBSITE

CONTACTS

ADDRESSES

SOCIAL LINKS

ONLINE SINCE

WEBSITE DETAILS

SEO

PAGES

SIMILAR SITES

TRAFFIC RANK FOR IR.NAVIDEA.COM

TODAY'S RATING

>1,000,000

TRAFFIC RANK - AVERAGE PER MONTH

BEST MONTH

April

AVERAGE PER DAY Of THE WEEK

HIGHEST TRAFFIC ON

Wednesday

TRAFFIC BY CITY

Sign up

CUSTOMER REVIEWS

Average Rating: 3.5 out of 5 with 6 reviews

5 star

1

4 star

1

3 star

4

2 star

0

1 star

0

Hey there! Start your review of ir.navidea.com

AVERAGE USER RATING

Write a Review

WEBSITE PREVIEW

LOAD TIME

CONTACTS AT IR.NAVIDEA.COM

ADD CONTACT

Login

TO VIEW CONTACTS

Remove Contacts

FOR PRIVACY ISSUES

CONTENT

PAGES IN
THIS WEBSITE

0

SSL

EXTERNAL LINKS

14

SITE IP

52.52.165.211

LOAD TIME

0 sec

SCORE

6.2

PAGE TITLE

Navidea Biopharmaceuticals Inc. -Investors | ir.navidea.com Reviews

<META> DESCRIPTION

Business Units and Joint Ventures. Annual Meeting and Proxy. Corporate Ethics and Conduct. Data as of 08/07/15 4:00 pm ET. Minimum 20 minute delay. Annual Meeting and Proxy. Navidea Reports Second Quarter 2015 Financial Results; Reiterates 2015 Lymphoseek Revenue Guidance. Navidea Awarded $1.7 Million Fast Track NIH SBIR Grant for Evaluation of Manocept in Rheumatoid Arthritis. Navidea and Massachusetts General Hospital to Evaluate Manocept for Detection of Cardiovascular Disease with NIH Grant.

<META> KEYWORDS

1 investors

2 media

3 about us

4 management

5 board of directors

6 history

7 lymphoseek

8 technology

9 manocept

10 publications

CONTENT

Page content here

KEYWORDS ON PAGE

investors,media,about us,management,board of directors,history,lymphoseek,technology,manocept,publications,pipeline,life cycle management,corporate overview,investor overview,stock info,advanced fundamentals,press releases,faq's,analyst coverage,rss feeds

CONTENT-TYPE

utf-8

GOOGLE PREVIEW

Navidea Biopharmaceuticals Inc. -Investors | ir.navidea.com Reviews

https://ir.navidea.com

Business Units and Joint Ventures. Annual Meeting and Proxy. Corporate Ethics and Conduct. Data as of 08/07/15 4:00 pm ET. Minimum 20 minute delay. Annual Meeting and Proxy. Navidea Reports Second Quarter 2015 Financial Results; Reiterates 2015 Lymphoseek Revenue Guidance. Navidea Awarded $1.7 Million Fast Track NIH SBIR Grant for Evaluation of Manocept in Rheumatoid Arthritis. Navidea and Massachusetts General Hospital to Evaluate Manocept for Detection of Cardiovascular Disease with NIH Grant.

LINKS TO THIS WEBSITE

navidea.com

Navidea Board of Directors

http://www.navidea.com/about-us/board-of-directors

Business Units and Joint Ventures. Navidea's management team and board of directors are leaders in research, development and commercialization of diagnostic agents and therapeutics. Michael M. Goldberg, M.D. Chairman of the Board. Managing Partner, Montaur Capital Partners. Tony Fiorino, M.D., Ph.D. Mark I. Greene, M.D., Ph.D. FRCP. Director of the Division of Immunology. University of Pennsylvania School of Medicine. LifeSci Advisors, LLC and LifeSci Capital, LLC. Eric K. Rowinsky, M.D.

navidea.com

Media and Press Information - Navidea

http://www.navidea.com/media

Business Units and Joint Ventures. If you are a member of the press or a journalist and would like to speak with us, please find our media contact listed below or complete our Request Information. 5600 Blazer Parkway, Suite 200, Dublin, OH 43017.

navidea.com

Business Units and Joint Ventures

http://www.navidea.com/about-us/business-units-and-joint-ventures

Business Units and Joint Ventures. Business Units and Joint Ventures. A newly formed subsidiary of Navidea Biopharmaceuticals, Inc., through use of the Manocept platform, a patented delivery system targeting CD206 on activated macrophages, is seeking to develop treatments for cancer, cardiovascular , autoimmune, antiviral and brain diseases. 5600 Blazer Parkway, Suite 200, Dublin, OH 43017.

navidea.com

Lymphoseek - Navidea

http://www.navidea.com/products/lymphoseek

Business Units and Joint Ventures. Lymphoseek (technetium Tc 99m tilmanocept) injection is a first-in-class mannose receptor (CD206) binding radiopharmaceutical agent developed for use in external lymph node imaging (lymphoscintigraphy), intra-operative lymphatic mapping (ILM). And sentinel lymph node biopsy. Lymphoseek Indication and Important Safety Information. Lymphoseek is a radioactive diagnostic agent indicated with or without scintigraphic imaging for:. Prior to the administration of Lymphoseek, ...

navidea.com

Sitemap

http://www.navidea.com/sitemap.html

Business Units and Joint Ventures. Business Units and Joint Ventures. Lymph Nodes in Cancer. Sentinel Lymph Node Biopsy. 5600 Blazer Parkway, Suite 200, Dublin, OH 43017.

navidea.com

NAV4694 Imaging Agent for diagnosing Alzheimer’s Disease

http://www.navidea.com/pipeline/nav4694.html

Business Units and Joint Ventures. NAV4694 Precision Imaging Agent to aid in Diagnosis of Alzheimer’s Disease. NAV4694 is a Fluorine-18 labeled precision radiopharmaceutical candidate for use in the imaging and evaluation of patients with signs or symptoms of cognitive impairment such as Alzheimer’s Disease (AD). NAV4694 is currently being evaluated in Phase 2b and Phase 3 registration clinical trials. 5600 Blazer Parkway, Suite 200, Dublin, OH 43017.

navidea.com

Navidea is focused on diagnostic and radiopharmaceutical imaging agents

http://www.navidea.com/about-us

Business Units and Joint Ventures. Today in the face of illness, millions of people are confronted with medical uncertainty. As patients and their physicians seek accurate diagnosis of their condition, precision diagnostics are playing important new roles in medicine, and are helping to inspire the growing presence of targeted treatments that define precision medicine today. Developing our innovative Manocept. Navidea’s products and pipeline. Lymphoseek ,(technetium Tc 99m tilmanocept) Injection a radiop...

navidea.com

Navidea Biopharmaceuticals History

http://www.navidea.com/about-us/history

Business Units and Joint Ventures. Navidea Biopharmaceuticals was founded as Neoprobe Corporation in 1983. With the sale of the neoprobe. GDS medical device business in 2011, Navidea Biopharmaceuticals was born. This event aimed to give Navidea management. Greater strategic flexibility to drive long-term earnings growth and shareholder return. The Company's transformation into a biopharmaceutical company is focused on the development and commercialization of precision diagnostics and radiopharmaceuti...

navidea.com

Life Cycle Management

http://www.navidea.com/pipeline/life-cycle-management.html

Business Units and Joint Ventures. What We Are Working On. In addition to our approved product, Lymphoseek. 5600 Blazer Parkway, Suite 200, Dublin, OH 43017.

UPGRADE TO PREMIUM TO VIEW 5 MORE

TOTAL LINKS TO THIS WEBSITE

14

OTHER SITES

ir.nantkwest.com

Overview | Investor Relations | Nantkwest

Skip to main content. We are committed to serving the best interests of our shareholders. You will find key shareholder information and financial reports available to help put NantKwest, Inc.'s financial performance into perspective. NantKwest Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares. NantKwest Announces Pricing of Initial Public Offering. NantKwest Announces Launch of Initial Public Offering. 160; 1.83.

ir.nasdaqomx.com

Investor Relations

The NASDAQ Stock Market LLC. NASDAQ OMX PHLX LLC. NASDAQ Futures, Inc. (NFX). NASDAQ OMX Nordic Ltd. Stock Quote and Chart. The NASDAQ OMX Group, Inc. (NASDAQ: NDAQ). 4:00 PM ET on Aug 7, 2015. July 23rd, 2015. NASDAQ Second Quarter 2015 Results. Q2 15 Earnings Press Release. PDF, 364.8 KB. Q2 15 Earnings Presentation. PDF, 1.0 MB. Q2 15 Summary Financial Statements. XLSX, 178.7 KB. Q2 15 Earnings Transcript. PDF, 182.3 KB. Or http:/ business.nasdaq.com. By Phone: 1 212-401-8742 (USA). July 23rd, 2015.

ir.nationalbeverage.com

National Beverage Corp. - Investor Relations

8902 ( 1.99%). 3/29/2018 4:00 PM ET. Annual Reports and Other. National Beverage Corp. (. Proudly refreshes America with a distinctive portfolio of Sparkling Waters, Juices, Energy Drinks and Carbonated Soft Drinks. We believe our ingenious product designs, innovative packaging and imaginative flavors, along with our corporate culture and philosophy, make National Beverage unique in the beverage industry. Fun, Flavor and Vitality . . . the National Beverage Way! Mar 8, 2018. Dec 18, 2017.

ir.nationalmi.com

NMI Holdings, Inc. - Investor Relations

National MI vs. FHA. National MI AXIS Online. We are committed to serving the best interests of our shareholders. You will find key shareholder information and financial reports available to help put NMI Holdings, Inc.'s financial performance into perspective. View all ». Aug 5, 2015. National MI's Claudia Merkle Recognized as Industry Leader by MReport. Aug 4, 2015. NMI Holdings, Inc. Reports Second Quarter 2015 Financial Results, New Insurance Written Grows 50% Sequentially. Find a Sales Advisor.

ir.navarre.com

Speed commerce

Q1 2016 Speed Commerce Inc Earnings Conference Call. 160;at 10:00 am ET. Q1 2016 Speed Commerce Inc Earnings Conference Call. Monday, August 10, 2015 . 10:00 am ET . Click here for webcast. Click here to add this event to your calendar. 160; 0.01. Data as of 08/07/15 4:00 pm ET. Minimum 20 minute delay. Speed Commerce Sets Fiscal First Quarter 2016 Conference Call for Monday, August 10, 2015 at 10:00 am ET. Speed Commerce Reports Fiscal Fourth Quarter and Full Year 2015 Results. Replication or redistrib...

ir.navidea.com

Navidea Biopharmaceuticals Inc. -Investors

Business Units and Joint Ventures. Annual Meeting and Proxy. Corporate Ethics and Conduct. Data as of 08/07/15 4:00 pm ET. Minimum 20 minute delay. Annual Meeting and Proxy. Navidea Reports Second Quarter 2015 Financial Results; Reiterates 2015 Lymphoseek Revenue Guidance. Navidea Awarded $1.7 Million Fast Track NIH SBIR Grant for Evaluation of Manocept in Rheumatoid Arthritis. Navidea and Massachusetts General Hospital to Evaluate Manocept for Detection of Cardiovascular Disease with NIH Grant.

ir.navios-acquisition.com

Navios Maritime Acquisition Corp - Investor Relations -Investor Overview

Navios Maritime Acquisition Corporation (â œNavios Acquisitionâ ) is an owner and operator of tanker vessels focusing in the transportation of petroleum products (clean and dirty) and bulk liquid chemicals. The Company is publicly traded on the New York Stock Exchange under the ticker â œNNA. 160; 0.10. Data as of 08/07/15Â 4:00 pm ET. Minimum 20 minute delay. There are currently no events scheduled. Navios Group Closes Second Transaction With HSH Nordbank AG. Acquired 14 Vessels With Fair Market Value o...

ir.navios-midstream.com

Navios Maritime Midstream Partners L.P. - Investor Relations -Investor Overview

Navios Maritime Midstream Partners L.P. (Navios Midstream) is a publicly listed master limited partnership on the New York Stock Exchange under the symbol â œNAP.â. Navios Midstream owns and operates very large crude oil tankers under long-term employment contracts with international oil companies, refiners, and large vessel operators. Navios Midstreamâ s initial fleet consists of four VLCCs, which have an average remaining term on their charters of approximately 7.7 years. Q2 2015 Earnings Presentation.

ir.navistar.com

Navistar International Corporation - Investor Relations

ir.nayana.com

¹Ì·¡¸¦ °³Ã´ÇÏ´Â ÀÎÅÍ³Ý³ª¾ß³ª! ÀÎÅÍ³Ý¼¼»óÀÇ Áß½ÉÀÌ µÇ°Ú½À´Ï´Ù.

Á È ºÆÃ ºñ º Á á È. ÇÁ Î ð Ç È ºÆÃ ºñ º Á á È. 2018 â ÈÞ í ÅÍ î µ È. IPV6 ç Á á Î ÀÎÇÑ IPV6 È ºÆÃ óÇ . KR µµ ÞÀÎ ÀÏ ý â ü ÀÌÀü µû ÜÀÌ.

ir.nctu.edu.tw

National Chiao Tung University Institutional Repository：Home

Yuyu Yang Digital Art Museum. Kuan Digital Art Museum. Journal of Management and System. Du Chuan Bo Yu Ke Ji. Journal of Cyber Culture and Information Society. Chiao Da Mangement Review. Mathematics, Science, History, and Culture. Collections of Publications of NCTU Researchers and Students Like Journal Papers and Thesis. Collections of Students' Thematic Works and Research Activities like Castnet and University Study Projects. Try to Retrieve the Memories from School Time? Here Is the Right Place to Go.